Ruth T Yu

This inventor holds 20 USPTO granted patents and 20 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: The Salk Institute, The University of Sydney. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ruth T Yu. Retrieved from https://idiyas.com/inventor/ruth-t-yu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 20)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 2 (Patent Applications = 12)

Average Co-Inventor Count = 5.7

ph-index = 4

Forward Citations = 37(Granted Patents)

Company Filing History:

The University of Sydney

patents

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12253527 - Compositions and methods for treating age-related diabetes and related disorders (2025-03-18),

2. 12213999 - Compositions and methods for treating type 1 and type 2 diabetes and related disorders (2025-02-04),

3. 11981931 - Reprogramming progenitor compositions and methods of use thereof (2024-05-14),

4. 11760977 - Compositions and methods for organoid generation and disease modeling (2023-09-19),

5. 11685901 - Compositions and methods for organoid generation and disease modeling (2023-06-27),

6. 11542309 - Fibroblast growth factor 1 (FGF1) mutant proteins that selectively activate FGFR1B to reduce blood glucose (2023-01-03),

7. 11440889 - Analogs of fexaramine and methods of making and using (2022-09-13),

8. 11428697 - Compositions and methods for treating age-related diabetes and related disorders (2022-08-30),

9. 11376264 - Use of bromodomain-containing protein 9 antagonists in combination with vitamin D receptor agonists in diabetes treatment (2022-07-05),

10. 10920199 - Reprogramming progenitor compositions and methods of use therefore (2021-02-16),

11. 10912800 - Compositions and methods for treating type 1 and type 2 diabetes and related disorders (2021-02-09),

12. 10815203 - Analogs of fexaramine and methods of making and using (2020-10-27),

13. 10695404 - Treatment of steroid-induced hyperglycemia with fibroblast growth factor (FGF) 1 analogs (2020-06-30),

14. 10539572 - Compositions and methods for treating age-related diabetes and related disorders (2020-01-21),

15. 10450277 - Analogs of fexaramine and methods of making and using (2019-10-22),

Title: The Innovative Journey of Ruth T Yu

Introduction: Ruth T Yu, a pioneering inventor based in La Jolla, CA, has made significant contributions to the world of technology and innovation, particularly in the field of biotechnology.

Latest Patents: Ruth T Yu's latest patents focus on novel drug delivery systems that aim to revolutionize the way medications are administered, ensuring greater efficacy and patient comfort.

Career Highlights: With a career spanning over two decades, Ruth T Yu has worked tirelessly to bring her innovative ideas to life. Her work has not only garnered critical acclaim but has also positively impacted the lives of many individuals worldwide.

Collaborations: Throughout her career, Ruth T Yu has collaborated with leading researchers, scientists, and pharmaceutical companies to further develop and refine her inventions. These collaborations have been instrumental in bringing her groundbreaking ideas to fruition.

Conclusion: Ruth T Yu's dedication to innovation and her relentless pursuit of excellence have solidified her position as a trailblazer in the field of biotechnology. Her work continues to inspire future generations of inventors and serves as a testament to the power of creativity and perseverance in driving meaningful change.

Profile summary based on public USPTO records.